CA
JAZZ icon

Clearstead Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Clearstead Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.1K Buy
233
+230
+7,667% +$50.4K ﹤0.01% 1467
2026
Q1 		$568 Sell
3
-21
-88% -$3.67K ﹤0.01% 2106
2025
Q4 		$4.08K Sell
24
-44
-65% -$6.75K ﹤0.01% 2053
2025
Q3 		$8.96K Sell
68
-48
-41% -$5.76K ﹤0.01% 1959
2025
Q2 		$12.3K Buy
116
+31
+36% +$3.37K ﹤0.01% 1818
2025
Q1 		$10.6K Buy
85
+74
+673% +$9.65K ﹤0.01% 1594
2024
Q4 		$1.35K Buy
11
+1
+10% +$118 ﹤0.01% 1892
2024
Q3 		$1.11K Hold
10
– – ﹤0.01% 1902
2024
Q2 		$1.07K Hold
10
– – ﹤0.01% 1892
2024
Q1 		$1.13K Hold
10
– – ﹤0.01% 1388
2023
Q4 		$1.23K Hold
10
– – ﹤0.01% 1375
2023
Q3 		$1.29K Sell
10
-2
-17% -$266 ﹤0.01% 1318
2023
Q2 		$1.49K Hold
12
– – ﹤0.01% 1203
2023
Q1 		$1.76K Hold
12
– – ﹤0.01% 1156
2022
Q4 		$1.91K Hold
12
– – ﹤0.01% 1098
2022
Q3 		$2K Hold
12
– – ﹤0.01% 1081
2022
Q2 		$2K Hold
12
– – ﹤0.01% 1110
2022
Q1 		$2K Hold
12
– – ﹤0.01% 1207
2021
Q4 		$2K Sell
12
-24
-67% -$3.15K ﹤0.01% 1113
2021
Q3 		$5K Hold
36
– – ﹤0.01% 1025
2021
Q2 		$6K Buy
+36
New +$6.24K ﹤0.01% 859

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Clearstead Advisors's JAZZ Position: Q2 2026 in Review

Clearstead Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 7,667% in Q2 2026, buying an estimated $50.4K and bringing the position to 233 shares worth $56.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

Clearstead Advisors first reported a position in JAZZ in Q2 2021 and has held it in 21 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Clearstead Advisors held 233 shares of Jazz Pharmaceuticals worth $56.1K as of Q2 2026.
  • Clearstead Advisors bought 230 Jazz Pharmaceuticals shares in Q2 2026, an estimated $50.4K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1467 holding.
  • Clearstead Advisors first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.